Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells

References

• BruixJQinSMerlePRESORCE InvestigatorsRegorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialLancet201738910064566627932229
   PubMed Web of Science ®Google Scholar
• WangFSFanJGZhangZGaoBWangHYThe global burden of liver disease: the major impact of ChinaHepatology20146062099210825164003
   PubMed Web of Science ®Google Scholar
• KulikLHeimbachJKZaiemFTherapies for patients with hepatocellular carcinoma awaiting liver transplantation: a systematic review and meta-analysisHepatology201867138140028859222
   PubMed Web of Science ®Google Scholar
• JiaHYangQWangTRhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agentsBiochim Biophys Acta2016186071417143027091611
   PubMed Web of Science ®Google Scholar
• KisselMBerndtSFiebigLAntitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinomaOncotarget201786310709610710829291014
   PubMedGoogle Scholar
• GyawaliBPrasadVMe too-drugs with limited benefits – the tale of regorafenib for HCCNat Rev Clin Oncol20181516229182165
   PubMed Web of Science ®Google Scholar
• ZhuYJZhengBWangHYChenLNew knowledge of the mechanisms of sorafenib resistance in liver cancerActa Pharmacol Sin201738561462228344323
   PubMed Web of Science ®Google Scholar
• GoodmanMNaimanDQLaKindJSSystematic review of the literature on triclosan and health outcomes in humansCrit Rev Toxicol201725151
   Google Scholar
• WeatherlyLMGosseJATriclosan exposure, transformation, and human health effectsJ Toxicol Environ Health B Crit Rev201720844746929182464
   PubMed Web of Science ®Google Scholar
• YuehMFTaniguchiKChenSThe commonly used antimicrobial additive triclosan is a liver tumor promoterProc Natl Acad Sci U S A201411148172001720525404284
   PubMed Web of Science ®Google Scholar
• ChenYFengFGaoXMiRNA153 reduces effects of chemotherapeutic agents or small molecular kinase inhibitor in HCC cellsCurr Cancer Drug Targets201515317618725714700
   PubMed Web of Science ®Google Scholar
• HouJHongZFengFA novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinomaBMC Cancer201717172929117859
   PubMed Web of Science ®Google Scholar
• JiQXuXLiLmiR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14Cell Death Dis2017810e310329022909
   PubMed Web of Science ®Google Scholar
• LiangYXuXWangTThe EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasisCell Death Dis201787e292828703807
   PubMed Web of Science ®Google Scholar
• ZhaoJBaiZFengFCross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cellInt J Biochem Cell Biol201672738826783937
   PubMed Web of Science ®Google Scholar
• LiuRZhaoDZhangXA20 enhances the radiosensitivity of hepatocellular carcinoma cells to 60Co-γ ionizing radiationOncotarget2017854931039311629190981
   PubMedGoogle Scholar
• AnLLiDDChuHXTerfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversalPharmacol Res201712410511528754458
   PubMed Web of Science ®Google Scholar
• AllardMKhoudourNRousseauBSimultaneous analysis of regorafenib and sorafenib and three of their metabolites in human plasma using LC-MS/MSJ Pharm Biomed Anal2017142424828494338
   PubMed Web of Science ®Google Scholar
• HeYZhouLGaoSDevelopment and validation of a sensitive LC-MS/MS method for simultaneous determination of eight tyrosine kinase inhibitors and its application in mice pharmacokinetic studiesJ Pharm Biomed Anal2018148657228965046
   PubMed Web of Science ®Google Scholar
• FengFJiangQCaoSPregnane X receptor mediates Sorafenib resistance in advanced hepatocellular carcinomaBiochim Biophys Acta201818621017103029369785
   PubMed Web of Science ®Google Scholar
• XuXFanZLiangCA signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivityNat Commun201781405928094252
   PubMed Web of Science ®Google Scholar
• Casadei GardiniAFaloppiLDe MatteisSMetformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: validation study and biological rationaleEur J Cancer20178610611428985579
   PubMed Web of Science ®Google Scholar
• GomaaAWakedIManagement of advanced hepatocellular carcinoma: review of current and potential therapiesHepatoma Res20173112122
   Google Scholar
• KimDWTalatiCKimRHepatocellular carcinoma (HCC): beyond sorafenib-chemotherapyJ Gastrointest Oncol20178225626528480065
   PubMed Web of Science ®Google Scholar
• WuJLiAYangJLuYLiJEfficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective studyOnco Targets Ther2017102761276828603426
   PubMed Web of Science ®Google Scholar
• RattanSZhouCChiangCMahalingamSBrehmEFlawsJAExposure to endocrine disruptors during adulthood: consequences for female fertilityJ Endocrinol20172333R109R12928356401
   PubMed Web of Science ®Google Scholar
• MaHYaoYWangCTranscription factor activity of estrogen receptor α activation upon nonylphenol or bisphenol A treatment enhances the in vitro proliferation, invasion, and migration of neuroblastoma cellsOnco Targets Ther201693451346327366082
   PubMed Web of Science ®Google Scholar
• BilslandEvan VlietLWilliamsKPlasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosanSci Rep201881103829348637
   PubMed Web of Science ®Google Scholar
• LeeGAChoiKCHwangKATreatment with phytoestrogens reversed triclosan and bisphenol A-induced anti-apoptosis in breast cancer cellsBiomol Ther (Seoul)2018 [Epub ahead of print]
   Web of Science ®Google Scholar
• LeeGAHwangKAChoiKCInhibitory effects of 3,3′-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancerFood Chem Toxicol2017109Pt 128429528844962
   PubMed Web of Science ®Google Scholar
• ParkJWJungKHLeeJHMoonSHChoYSLeeKHInhibition of aldehyde dehydrogenase 1 enhances the cytotoxic effect of retinaldehyde on A549 cancer cellsOncotarget20178993829939329245909
   PubMedGoogle Scholar
• XiaoYLiPChengYZhangQWangFEffect of α-linolenic acid-modified low molecular weight chondroitin sulfate on atherosclerosis in apoE-deficient miceBiochim Biophys Acta201618602589259727491336
   PubMed Web of Science ®Google Scholar
• MartinRDSunYBourqueKReceptor- and cellular compartment-specific activation of the cAMP/PKA pathway by α1-adrenergic and ETA endothelin receptorsCell Signal201844435029329779
   PubMed Web of Science ®Google Scholar
• MerlinJSatoMNowellCThe PPARγ agonist rosiglitazone promotes the induction of brite adipocytes, increasing β-adrenoceptor-mediated mitochondrial function and glucose uptakeCell Signal201842546628970184
   PubMed Web of Science ®Google Scholar
• ZhuWPLiuZYZhaoYMDihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinomaCell Death Dis201896929358721
   PubMed Web of Science ®Google Scholar
• BolgerGBThe RNA-binding protein SERBP1 interacts selectively with the signaling protein RACK1Cell Signal20173525626328267599
   PubMed Web of Science ®Google Scholar
• GuoSCarterRLGrisantiLAKochWJTilleyDGImpact of paroxetine on proximal β-adrenergic receptor signalingCell Signal20173812713328711716
   PubMed Web of Science ®Google Scholar
• PatilNABasuBDeobagkarDDApteSKDeobagkarDNPutative DNA modification methylase DR_C0020 of Deinococcus radiodurans is an atypical SAM dependent C-5 cytosine DNA methylaseBiochim Biophys Acta2017186159360228038990
   PubMed Web of Science ®Google Scholar
• DingGWangYChenYMethylenetetrahydrofolate reductase tagging polymorphisms are associated with risk of esophagogastric junction adenocarcinoma: a case-control study involving 2,740 Chinese Han subjectsOncotarget2017811148211149429340069
   PubMedGoogle Scholar
• LeeGAChoiKCHwangKAKaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cellsEnviron Toxicol Pharmacol201749485727902959
   PubMed Web of Science ®Google Scholar
• NiJZhouLLDingLPPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathwayExp Cell Res2017361224625629080795
   PubMed Web of Science ®Google Scholar
• KimSWHasanuzzamanMDChoMRole of 14-3-3 sigma in over-expression of P-gp by rifampin and paclitaxel stimulation through interaction with PXRCell Signal20173112413428077325
   PubMed Web of Science ®Google Scholar
• BrewerCTChenTPXR variants: the impact on drug metabolism and therapeutic responsesActa Pharm Sin B20166544144927709012
   PubMed Web of Science ®Google Scholar
• JusuSPresleyJFKremerRPhosphorylation of human retinoid X receptor α at serine 260 impairs its subcellular localization, receptor interaction, nuclear mobility, and 1α,25-Dihydroxyvitamin D3-dependent DNA binding in Ras-transformed keratinocytesJ Biol Chem201729241490150927852823
   PubMed Web of Science ®Google Scholar
• LundonDJBolandAPrencipeMThe prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validationBMC Cancer201717116328249598
   PubMed Web of Science ®Google Scholar
• LiuCLLimYPHuMLFucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cellsMar Drugs201210124225722363234
   PubMed Web of Science ®Google Scholar